AWMDMG
NVAX icon

Austin W. Marxe & David M. Greenhouse’s Novavax NVAX Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.38M Hold
28,500
– – 0.32% 81
2014
Q2 		$2.63M Hold
28,500
– – 0.33% 84
2014
Q1 		$2.58M Sell
28,500
-3,350
-11% -$374K 0.29% 83
2013
Q4 		$3.26M Hold
31,850
– – 0.35% 76
2013
Q3 		$2.01M Buy
+31,850
New +$1.79M 0.25% 88

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's NVAX Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Novavax (NVAX) position steady in Q3 2014 at 28,500 shares worth $2.38M. The position accounts for 0.32% of the portfolio, ranked #81.

Austin W. Marxe & David M. Greenhouse first reported a position in NVAX in Q3 2013 and has held it in 5 quarters since. The position peaked at $3.26M in Q4 2013. 143 funds tracked by Wall St. Rank hold NVAX as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 28,500 shares of Novavax worth $2.38M as of Q3 2014.
  • Austin W. Marxe & David M. Greenhouse left its Novavax share count unchanged in Q3 2014.
  • Novavax made up 0.32% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #81 holding.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Novavax in Q3 2013 and has held it in 5 quarters since.
  • Austin W. Marxe & David M. Greenhouse's Novavax position peaked at $3.26M in Q4 2013.
  • 143 funds tracked by Wall St. Rank held Novavax as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.